Kristina Torfgård
Amministratore Delegato presso ALZINOVA AB
Provenienza dei contatti di primo grado di Kristina Torfgård
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
18
| Public Company | Pharmaceuticals: Major | 18 |
| Subsidiary | Pharmaceuticals: Major | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kristina Torfgård tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Human Resources Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Human Resources Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director of Finance/CFO Human Resources Officer | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| INTEGER HOLDINGS CORPORATION | Medical Specialties | Human Resources Officer | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| TESARO INC | Pharmaceuticals: Major | Human Resources Officer | |
| Michigan State University | College/University | Graduate Degree | |
| ACTIVE BIOTECH AB | Biotechnology | Corporate Officer/Principal | |
SBL Vaccin AB
 SBL Vaccin AB Pharmaceuticals: MajorHealth Technology SBL Vaccin AB manufactures and distributes vaccines. Its products are used for the treatment of polio, diarrhoea, and cholera diseases. The company distributes products to the healthcare centers, hospitals, schools, and industrial healthcare units. SBL Vaccin was founded in 1957 and is located in Solna, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree | |
| University of Illinois | College/University | Undergraduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree Corporate Officer/Principal | |
| INDX PHAR | Pharmaceuticals: Major | Chief Operating Officer | |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO | |
| University of Gothenburg | College/University | Doctorate Degree | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member Corporate Officer/Principal | |
American Gastroenterological Association
 American Gastroenterological Association Miscellaneous Commercial ServicesCommercial Services American Gastroenterological Association engages in the science and practice of gastroenterology. The private company is based in Bethesda, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer | |
| Läkemedelsindustriföreningens Service AB | Director/Board Member | ||
| Mundipharma AB | Chief Executive Officer | ||
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member | |
| Norpharma A/S | Chief Executive Officer | ||
| Mundipharma AS | Chief Executive Officer | ||
| Mundipharma Oy | Chief Executive Officer | ||
| University of Linnaeus | College/University | Undergraduate Degree | |
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
| Pritzker School of Medicine | College/University | Doctorate Degree | |
| TOLERANZIA AB | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Stockholm Business School | College/University | Masters Business Admin | |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
Innovativa Mindre Life Science
 Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Miscellaneous Commercial Services | Director/Board Member | |
Maida Vale Capital AB
 Maida Vale Capital AB Investment Banks/BrokersFinance Maida Vale Capital AB is a private company based in Saltsjo-Boo, Sweden. The CEO of the Swedish company is Oliver Aleksov. | Investment Banks/Brokers | Director/Board Member Chairman | |
| Permeda AB | Chief Executive Officer | ||
| DANCANN PHARMA A/S | Pharmaceuticals: Other | Director/Board Member | |
Simplexia AB
 Simplexia AB BiotechnologyHealth Technology Simplexia AB is a company based in Gothenburg, Sweden that aims to launch the first vaccine for the treatment and prevention of genital herpes. The Swedish company is driven by the goal to curtail and treat infection with herpes simplex virus (HSV), one of the world's most prevalent sexually transmitted diseases. The team at Simplexia is composed of experts in pharmaceutical development, including Prof. Jan-Åke Liljeqvist and the Department of Virology at the Sahlgrenska Academy. The vaccine is based on research that showed glycoproteins from HSV-1 and 2, when administered as a vaccine, are highly immunogenic and provide protection in mouse models. | Biotechnology | Chairman | |
| Hunterhex AB | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 25 |
| Stati Uniti | 21 |
| Danimarca | 3 |
| Regno Unito | 2 |
| Norvegia | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Distribution Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 135 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 46 |
| Chief Tech/Sci/R&D Officer | 26 |
| Chief Executive Officer | 24 |
Contatti più connessi
| Insiders | |
|---|---|
| Heather Elizabeth Preston | 34 |
| Julia Brown | 27 |
| Karl Blom | 22 |
| Anders Waas | 21 |
| Denise Scots-Knight | 20 |
| Roger Jeffs | 18 |
| Lena Birgitta Degling Wikingsson | 16 |
| Thomas A. Shea | 15 |
| Anne Klibanski | 14 |
| Per-Göran Gillberg | 11 |
| Per Wester | 10 |
| Julian Aleksov | 10 |
| Patrick Taylor Horn | 10 |
| Simon Harford | 9 |
| Jason G. Duncan | 9 |
- Borsa valori
- Insiders
- Kristina Torfgård
- Connessioni Società
